Kingdon Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-200,000
Closed -$2.01M 78
2021
Q1
$2.01M Hold
200,000
0.21% 49
2020
Q4
$2.13M Buy
+200,000
New +$2.13M 0.23% 41